This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal...
Quest Diagnostics Acquires the Clinical Laboratory Services of Boston Clinical Laboratories in Massachusetts SECAUCUS, N.J. -- December 2, 2019 — Quest Diagnostics (NYSE:DGX), the world’s...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
A laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace...